Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 2/20 | 0.55 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.55 |
| ▸ | PRSS2 | P07478 | 2/20 | 0.55 |
| ▸ | PRSS3 | P35030 | 2/20 | 0.55 |
| ▸ | EDNRA | P25101 | 7/20 | 0.53 |
| ▸ | CA2 | P00918 | 1/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | NSD2 | O96028 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.50 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.50 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.50 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.50 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL867347 | 1.00 | F2 (0.55) | F2PRSS1PRSS2PRSS3EDNRA | |
| SCHEMBL29683331 | 1.00 | F2 (0.55) | F2PRSS1PRSS2PRSS3EDNRA | |
| Cyclohexylamine SCHEMBL30763312 | 0.88 | F2 (0.54) | F2PRSS1PRSS2PRSS3CA2 | |
| Cyclohexylamine SCHEMBL15918671 | 0.88 | F2 (0.54) | F2PRSS1PRSS2PRSS3CA2 | |
| Cyclohexylamine SCHEMBL29197249 | 0.88 | F2 (0.54) | F2PRSS1PRSS2PRSS3CA2 | |
| SCHEMBL10966272 | 0.87 | F2 (0.53) | F2PRSS1PRSS2PRSS3EDNRA | |
| SCHEMBL10965358 | 0.87 | F2 (0.53) | F2PRSS1PRSS2PRSS3EDNRA | |
| SCHEMBL10964796 | 0.86 | F2 (0.52) | F2PRSS1PRSS2PRSS3EDNRA | |
| SCHEMBL4128595 | 0.86 | F2 (0.52) | F2PRSS1PRSS2PRSS3EDNRA | |
| SCHEMBL28739997 | 0.86 | F2 (0.52) | F2PRSS1PRSS2PRSS3EDNRA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 171 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114195878-A | Ubiquitin mutant and preparation method and application thereof | 中国人民解放军军事科学院军事医学研究院 | 2022-03-18 | — | — | CN | claimed |
| EP-2889370-A1 | In vivo unnatural amino acid expression in the methylotrophic yeast Pichia pastoris | The Scripps Research Institute (US) | 2015-07-01 | — | — | EP | claimed |
| US-20140287464-A1 | In Vivo Unnatural Amino Acid Expression in the Methylotrophic Yeast Pichia Pastoris | SCRIPPS RESEARCH INST (US) | 2014-09-25 | — | — | US | claimed |
| US-20140170704-A1 | Production of Carrier-Peptide Conjugates Using Chemically Reactive Unnatural Amino Acids | THE SCRIPPS RESEARCH INSTITUTE (US) | 2014-06-19 | — | — | US | claimed |
| JP-2011527886-A | — | — | 2011-11-10 | — | — | JP | claimed |
| US-20110014650-A1 | IN VIVO UNNATURAL AMINO ACID EXPRESSION IN THE METHYLOTROPHIC YEAST PICHIA PASTORIS | THE SCRIPPS RESEARCH INSTITUTE | 2011-01-20 | — | — | US | claimed |
| EP-2231856-A2 | IN VIVO UNNATURAL AMINO ACID EXPRESSION IN THE METHYLOTROPHIC YEAST PICHIA PASTORIS | The Scripps Research Institute (US) | 2010-09-29 | — | — | EP | claimed |
| US-20090197339-A1 | In vivo unnatural amino acid expression in the methylotrophic yeast pichia pastoris | THE SCRIPPS RESEARCH INSTITUTE (US) | 2009-08-06 | — | — | US | claimed |
| WO-2009075847-A2 | IN VIVO UNNATURAL AMINO ACID EXPRESSION IN THE METHYLOTROPHIC YEAST PICHIA PASTORIS | THE SCRIPPS RESEARCH INSTITUTE (US) | 2009-06-18 | — | — | WO | claimed |
| US-20090081669-A1 | Fluorescent Assays Using Orthogonal tRNA - Aminoacyl Synthetase Pairs | ENCODE BIO, INC. (US) | 2009-03-26 | — | — | US | claimed |
| WO-2007090198-A2 | FLUORESCENT ASSAYS USING ORTHOGONAL TRNA - AMINOACYL SYNTHETASE PAIRS | ENCODE BIO, INC. (US) | 2007-08-09 | — | — | WO | claimed |
| EP-4727592-A1 | CONJUGATED MOLECULES | Valink Therapeutics Ltd (GB) | 2026-04-22 | — | — | EP | disclosed |
| EP-4725953-A1 | SELF-ASSEMBLING PEPTIDES AND HYDROGELS | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2026-04-15 | — | — | EP | disclosed |
| EP-4720264-A1 | AMINOACYL-TRNA SYNTHETASE SETS | United Kingdom Research and Innovation (GB) | 2026-04-08 | — | — | EP | disclosed |
| US-12551572-B2 | Modified viral particles for gene therapy | EUROPEAN MOLECULAR BIOLOGY LABORATORY (DE) | 2026-02-17 | — | — | US | disclosed |
| US-5460943-A | Projecting monochromatic light to a sample, measuring the fluorescence intensity emitted by 4-methylumbelliferone which is converted by the enzyme from the substrate | TOSOH CORPORATION (JP) | 1995-10-24 | — | — | US | disclosed |
| CN-1100200-A | Capillary electrophoretic sampling device without electric discrimination | CHEMSTRY INST CHINESE ACADEMY (CN) | 1995-03-15 | — | — | CN | disclosed |
| EP-0521636-A1 | Method of assay of enzymatic activity and apparatus therefor | TOSOH CORPORATION (JP) | 1993-01-07 | — | — | EP | disclosed |
| US-4540548-A | Method of detecting fluorescent materials and apparatus for their detection | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) | 1985-09-10 | — | — | US | disclosed |
| US-4419452-A | Method of detecting fluorescent materials and apparatus for their detection | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) | 1983-12-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12551572-B2 | Modified viral particles for gene therapy | SMCHD1, SMC1A, TIMCC | F2 2929/4885PRSS1 2477/4885PRSS2 4075/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.